AstraZeneca
Anglo-Swedish
AztraZeneca
hit
have
had
has
hoped
helping
by
be
better
blockbuster
brokers
board.
drug
drugs
down
did
disease.
director
development
development.
determined
failure
failing...
facing
for
forward
follows
Shares
in
involving
its
is
improve
closed
clinical
cancer
cholesterol
charge
changes
chief
concerns.
confidence
company
8%
UK
US
trade
trial
trial.
the
three
that
than
two
to
a
after
anti-coagulant
another
and
analyst
at
against
already
appointed
am
of
on
organisation
our
Iressa
major
made
make
money
mounting
meant
medicine
The
This
Turner,
Tarceva
Tarceva.
Tom
lung
lives
life
no
not
now
new
significantly
survival
successful
setback
spinners
safety
said
shareholders,"
prolong
proved
processes".
patients
patients.
pill
pitch
power
placebo
performance,
with
will
would
were
we've
group
got
rejection
regulatory
restore
risks
rival
October
OSI
Exanta.
Meanwhile,
Mr
McKillop.
-
Crestor
Crestor,"
"This
"substantial
"I
Nick
Jefferies.
John
But
extending
executive
1,692
Pharmaceuticals,
Patterson
Genentech
Roche
value